Zogenix, Inc.’s (ZGNX) Migraine Treatment Receives Top Ranking as Most Innovative Life Sciences Product

QualityStocks would like to highlight Zogenix, Inc. (NASDAQ: ZGNX). With offices in San Diego and Emeryville, California, Zogenix is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL(R) DosePro(TM) (sumatriptan injection) Needle-free Delivery System, was launched in January 2010, for the acute treatment of migraine and cluster headache.

In the company’s news yesterday,

Zogenix, Inc. announced that CONNECT, a regional San Diego nonprofit organization, has selected Zogenix’s migrane treatment SUMAVEL(R) DosePro™ Needle-free Delivery System as a 2010 Most Innovative Product (MIP) winner.

The 2010 CONNECT MIP Awards recognize emerging technologies and cutting-edge products that drive San Diego’s innovation economy. SUMAVEL DosePro was awarded top ranking as the most innovative product for 2010 in the Life Sciences — Medical Products category.

SUMAVEL DosePro is a needle-free, quick response treatment for migraine attacks. The treatment is the first drug product approved by the U.S. Food and Drug Administration (FDA), which allows for the needle-free, subcutaneous delivery of medication.

“We are honored that CONNECT has recognized SUMAVEL DosePro, and by extension our proprietary DosePro delivery system, as a significant innovation. San Diego is a rich source of new and exciting technologies, and we are proud to be distinguished in the region as the most innovative medical product within the life sciences category,” Roger L. Hawley, CEO and director of Zogenix, stated in the press release.

Zogenix and its co-promotion partner Astellas Pharma US Inc. launched SUMAVEL DosePro in the United States in January 2010. Zogenix established a partnership with Desitin Arzneimittel GmbH to develop and commercialize SUMAVEL DosePro in the European Union, and the companies plan to launch SUMAVEL DosePro in Denmark in early 2011.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.